Actively Recruiting
Special Drug Use-results Survey for Long-term Use（Avacopan）
Led by Kissei Pharmaceutical Co., Ltd. · Updated on 2025-01-17
250
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
CONDITIONS
Official Title
Special Drug Use-results Survey for Long-term Use（Avacopan）
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Research site
Multiple Locations, Japan
Actively Recruiting
Research Team
K
Kazunori Abe, director
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here